GUSELKUMAB: DESCRIPTION OF CARDIOVASCULAR RISK AND EFFICACY IN PSORIASIS AND PSORIATIC ARTHRITIS IN REAL CLINICAL PRACTICE

被引：0
|
作者：
Gilabert, A. Navarro [1 ]
Andujar, S. Rufian [2 ]
Gil, A. Perez [1 ]
Perez, C. Azabal [3 ]
Hernandez, R. [3 ]
机构：
[1] Hosp Valme, Dermatol, Seville, Spain
[2] Hosp Valme, Cardiol, Seville, Spain
[3] Hosp Valme, Rheumatol, Seville, Spain
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷
关键词：
D O I：
10.1136/annrheumdis-2022-eular.849
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0882
引用
下载
收藏
页码：1564 / 1564
页数：1
相关论文
共 50 条
  • [31] Secukinumab as Biological Treatment for Psoriatic Arthritis in Real Clinical Practice
    Pinto Tasende, Jose A.
    Maceiras Pan, Francisco J.
    Mosquera Martinez, Jose A.
    Fernandez Dominguez, Luis
    Correa Rey, Blanca
    Garcia Porrua, Carlos
    REUMATOLOGIA CLINICA, 2021, 17 (04): : 203 - 206
  • [32] TOWARDS A GLOBAL MANAGEMENT OF PSORIATIC ARTHRITIS: ESTIMATION OF THE CARDIOVASCULAR RISK AND THE ACTIVITY OF THE DISEASE IN CLINICAL PRACTICE
    Lorenzo Martin, Jose Andres
    Pardo Campo, Estefania
    Pino Martinez, Marina
    Charca Benavente, Lilian Consuelo
    Arboleya Rodriguez, Luis Marcelino
    Alonso Castro, Sara
    Alperi-Lopez, Mercedes
    Javier Ballina-Garcia, Francisco
    Queiro Silva, Ruben
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1859 - 1859
  • [33] Prevention and risk assessment of cardiovascular events in a population of patients with psoriasis and psoriatic arthritis
    Olszewski, Robert
    Cwiklinska, Klaudia
    Maslinska, Maria
    Kwiatkowska, Brygida
    REUMATOLOGIA, 2022, 60 (04): : 266 - 274
  • [34] Incidence and Prevalence of Cardiovascular Risk Factors Among Patients With Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis
    Radner, Helga
    Lesperance, Tamara
    Accortt, Neil A.
    Solomon, Daniel H.
    ARTHRITIS CARE & RESEARCH, 2017, 69 (10) : 1510 - 1518
  • [35] INCIDENCE AND PREVALENCE OF CARDIOVASCULAR RISK FACTORS AMONG PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIASIS, OR PSORIATIC ARTHRITIS
    Solomon, D. H.
    Lesperance, T.
    Radner, H.
    Accortt, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 411 - 411
  • [36] Efficacy of adalimumab in psoriatic arthritis (PsA) in real-life clinical practice: Preliminary results of STEREO
    Van den Bosch, Filip
    Manger, Bernhard
    Frank, Martina
    Kupper, Hartmut
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (02) : AB184 - AB184
  • [37] Score Classification Underestimates the Real Cardiovascular Risk in Psoriatic Arthritis Patients
    Paz Martinez-Vidal, Maria
    Fernandez-Carballido, Cristina
    Sivera, Francisca
    Martin-Domenech, Raquel
    Martinez-Alberola, Nieves
    San Martin, Alejandro
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [38] Adverse Cardiovascular Events In Patients With Psoriasis And Psoriatic Arthritis
    Ottensoser, Molly
    Berger, Jeffrey
    Garshick, Michael S.
    CIRCULATION, 2022, 145
  • [39] DESCRIPTION OF THE REAL-WORLD TREATMENT PATTERNS OF GUSELKUMAB IN THE MANAGEMENT OF PSORIATIC ARTHRITIS IN AUSTRALIA: AN ANALYSIS FROM THE OPAL DATASET
    Littlejohn, G.
    Anbumurali, N.
    Bird, P.
    Youssef, P.
    Osullivan, C.
    Smith, T.
    Sumpton, D.
    Kane, B.
    Mcgeachie, A.
    Spiers, S.
    Deakin, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1785 - 1785
  • [40] Prospective cohort study of psoriatic arthritis risk in patients with psoriasis in a real-world psoriasis registry
    Ogdie, Alexis
    Harrison, Ryan W.
    McLean, Robert R.
    Lin, Tin-chi
    Lebwohl, Mark
    Strober, Bruce E.
    Zhuo, Joe
    Patel, Vardhaman
    Mease, Philip J.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (06) : 1303 - 1311
12345